Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
NCT00094640
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Schizoaffective Disorder
Interventions
DRUG:
Intramuscular Olanzapine Depot
Sponsor
Eli Lilly and Company